← All BCACP Flashcard Decks

Ambulatory Practice Management Flashcards

7 cards from real BCACP practice questions. Tap to flip, then mark Knew It or Still Learning — missed cards come back until you master them.

Read the first 7 Ambulatory Practice Management flashcards as text
  1. A pharmacist is conducting a quality improvement (QI) project using the PDSA cycle. After completing the 'Study' phase, which step comes next?

    Answer: Act

    The PDSA cycle proceeds Plan → Do → Study → Act; in the Act phase, the team decides whether to adopt, adapt, or abandon the change based on study findings.

  2. Which measure is an example of a process measure in ambulatory pharmacy quality reporting?

    Answer: Percentage of diabetic patients with HbA1c tested annually

    Process measures assess whether recommended care steps are performed, such as annual HbA1c testing for diabetic patients, rather than the final health outcome.

  3. Under HIPAA, which of the following activities by a pharmacist is permitted without specific patient authorization?

    Answer: Disclosing PHI to the patient's treating cardiologist for treatment purposes

    HIPAA's Treatment, Payment, and Operations (TPO) exceptions allow disclosure of PHI to other treating providers without specific patient authorization.

  4. A pharmacist notices that a clinic's statin prescribing rate for patients with established ASCVD is only 60%. This gap is best addressed first by performing which action?

    Answer: Conducting a root cause analysis to identify barriers to prescribing

    A root cause analysis identifies the underlying reasons for the prescribing gap before implementing targeted interventions to improve performance.

  5. Which of the following is a key component of the Pharmacist's Patient Care Process (PPCP) that distinguishes it from traditional dispensing?

    Answer: Collect, Assess, Plan, Implement, Follow-up

    The PPCP defined by JCPP consists of five steps: Collect, Assess, Plan, Implement, and Follow-up to evaluate effectiveness.

  6. A clinical pharmacist wants to demonstrate value to hospital administration for expanding an ambulatory care service. Which type of data would most effectively support this business case?

    Answer: Cost savings from averted adverse drug events and hospitalizations

    Quantifying cost savings from prevented adverse drug events and hospitalizations directly demonstrates the financial return on investment to administration.

  7. In an ambulatory care setting, which scheduling model best supports panel management for a pharmacist managing a chronic disease population?

    Answer: Proactive planned care with pre-visit preparation and population outreach

    Proactive planned care with pre-visit preparation and population-level outreach is the foundation of effective panel management in chronic disease care.